Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Michelle Gleeson"'
Autor:
Mark D. Danese, Melinda Daumont, Esmond Nwokeji, Michelle Gleeson, John R. Penrod, Deborah Lubeck
Publikováno v:
Cancer Reports, Vol 5, Iss 9, Pp n/a-n/a (2022)
Abstract Background Malignant mesothelioma is a rare neoplasm associated with asbestos exposure. Characterizing treatment patterns and outcomes of older patients with advanced malignant pleural mesothelioma (MPM) is important to understand the unmet
Externí odkaz:
https://doaj.org/article/1df522161be546ffa18c2f406d9b0670
Autor:
Michelle Gleeson, Mark Danese, Eduard Sidelnikov, Guillermo Villa, David Catterick, Mazhar Iqbal, Deborah Lubeck, Jeetesh Patel
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Objectives To compare treatment patterns, risk factors and cardiovascular disease (CVD) event rates in the UK from 2008 to 2017.Design Retrospective cohort study using the Clinical Practice Research Datalink.Setting UK primary care.Participants We se
Externí odkaz:
https://doaj.org/article/49c3dce06fd44dbfb87dbb86aab6c47f
Autor:
Michelle Gleeson
We can't avoid insects. They scurry past us in the kitchen, pop up in our gardens, or are presented to us in jars by inquisitive children. Despite encountering them on a daily basis, most people don't know an aphid from an antlion, and identifying an
Autor:
Ning Wu, Wenzhen Ge, Ruben GW Quek, Michelle Gleeson, Jean-Francois Pouliot, Hilary Dietz, Jessica J Jalbert, James Harnett, Scott J Antonia
Publikováno v:
Future Oncology. 18:4385-4397
Background: Trends/outcomes associated with National Comprehensive Cancer Network (NCCN)-recommended biomarker testing to guide advanced non-small-cell lung cancer (aNSCLC) treatment were assessed. Methods: Patients initiating first-line aNSCLC treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49ccf78a5453c762450a7f6e95baf4e0
https://doi.org/10.2217/fon-2022-0540
https://doi.org/10.2217/fon-2022-0540
Autor:
Mark Danese, Eduard Sidelnikov, Guillermo Villa, David Catterick, Mazhar Iqbal, Michelle Gleeson, Deborah Lubeck, Jeetesh Patel
Publikováno v:
BMJ open. 12(4)
ObjectivesTo compare treatment patterns, risk factors and cardiovascular disease (CVD) event rates in the UK from 2008 to 2017.DesignRetrospective cohort study using the Clinical Practice Research Datalink.SettingUK primary care.ParticipantsWe select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84c3ec84d63121a346b568cc4c2f10c7
https://pubmed.ncbi.nlm.nih.gov/35487737
https://pubmed.ncbi.nlm.nih.gov/35487737
Autor:
Pooja Desai, Kevin J. Martin, Tzu-Chieh Lin, Mark D. Danese, Michel Chonchol, Vasily Belozeroff, Michelle Gleeson, Deborah P. Lubeck
Publikováno v:
American Journal of Nephrology. 51:815-822
Background: Calcimimetics are used to treat mineral and bone disorder by reducing parathyroid hormone (PTH), calcium (Ca), and phosphorus (Phos). The study objectives were to assess the control of PTH, Ca, and Phos over time in patients receiving cin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20552db6e108a2bdffd47220570d2745
https://doi.org/10.1159/000510360
https://doi.org/10.1159/000510360
Autor:
Deborah P. Lubeck, Melinda Daumont, Mark D. Danese, John R. Penrod, Michelle Gleeson, E. Nwokeji
Publikováno v:
Cancer reports (Hoboken, N.J.). 5(9)
Background Malignant mesothelioma is a rare neoplasm associated with asbestos exposure. Characterizing treatment patterns and outcomes of older patients with advanced malignant pleural mesothelioma (MPM) is important to understand the unmet needs of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2fb0a91b3fce09a9445e9a97f0b30c7
https://pubmed.ncbi.nlm.nih.gov/34698447
https://pubmed.ncbi.nlm.nih.gov/34698447
Autor:
Mark D. Danese, Jeetvan Patel, D. Catterick, M. Iqbal, Eduard Sidelnikov, Deborah P. Lubeck, G. Villa, Y. Beaini, Michelle Gleeson
Publikováno v:
European Heart Journal. 41
Background Over time, guidelines for dyslipidemia management in patients at high risk of atherosclerotic cardiovascular disease (CVD) changed with the goal of improving patient outcomes. Guidelines have been released by the European Joint Task Force
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d07f0b94570ee9d384553113e44ce6b9
https://doi.org/10.1093/ehjci/ehaa946.3510
https://doi.org/10.1093/ehjci/ehaa946.3510
Autor:
Y. Beaini, Mark D. Danese, D. Catterick, M. Iqbal, Jeetvan Patel, Eduard Sidelnikov, Deborah P. Lubeck, Michelle Gleeson, G. Villa
Publikováno v:
Value in Health. 23:S499-S500
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89962a40b0c8692cd22bca461765055c
https://doi.org/10.1016/j.jval.2020.08.565
https://doi.org/10.1016/j.jval.2020.08.565
Publikováno v:
Journal of Medical Economics. 20:931-937
Aims: Methods for integrating external costs into clinical databases are not well-characterized. The purpose of this research was to describe and implement methods for estimating the cost of hospitalizations, prescriptions, and general practitioner a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c69d72f2bd684196d3b025b6e4717cc6
https://doi.org/10.1080/13696998.2017.1345747
https://doi.org/10.1080/13696998.2017.1345747